Last updated: June 4, 2026

TL;DR

Clinical-strength OTC and prescription antiperspirants both use aluminum chloride as the active ingredient. Prescription formulas use higher concentrations available only through a physician. Most people with heavy sweating and hyperhidrosis respond to clinical-strength OTC applied correctly before needing a prescription. DryDry Original is the clinical-strength OTC option, with over 5 million units sold across European markets since 2006.

What is the difference between OTC clinical-strength and prescription antiperspirant?

Both use aluminum chloride to form a gel plug inside the sweat duct that physically reduces sweat output. The difference is concentration. OTC clinical-strength formulas use aluminum chloride within the concentration range permitted for over-the-counter sale. Prescription formulas use higher concentrations, available only through a physician or dermatologist, for cases where OTC concentrations have not produced adequate sweat control after a proper trial.

According to the American Academy of Dermatology, topical aluminum chloride is the first-line treatment for hyperhidrosis at both OTC and prescription concentrations. The mechanism is identical; the prescription option is simply a higher dose of the same active ingredient for cases that require it.

The practical implication: most people who have "tried everything" and believe antiperspirant does not work for them have tried standard pharmacy products, not true clinical-strength OTC. The first step before requesting a prescription is confirming that clinical-strength OTC has been used correctly, meaning evening application on dry skin with the two-night loading period, not morning application the way standard antiperspirants are used.

When does someone actually need prescription-strength antiperspirant?

A prescription-strength formula is appropriate when 4 to 6 weeks of correct clinical-strength OTC application on a maintenance schedule has not produced acceptable sweat control. The AAD's treatment ladder places clinical-strength OTC at step one, prescription-strength at step two, and procedural options like iontophoresis and botulinum toxin injections at steps three and four.

Three situations typically indicate that OTC clinical-strength is not sufficient and prescription evaluation is appropriate:

  • Breakthrough sweating persists after the full loading period on the highest OTC concentration. If the DryDry Original applied correctly on a two-times-per-week maintenance schedule still leaves visible sweat through clothing by mid-morning, the OTC concentration may be insufficient for the individual's sweat volume.
  • The protection window is consistently shorter than 24 hours despite correct application. Very high eccrine gland density or output can consume the protective capacity of the OTC gel plug within a single day. Prescription concentrations build a deeper plug that holds for longer under those conditions.
  • OTC application causes consistent skin irritation even with the alcohol-free Sensitive formula. If the Sensitive formula still causes reactions at the lower OTC concentration, a physician can prescribe an optimized formulation or a different delivery vehicle alongside a higher active ingredient concentration.

Why do most heavy sweaters succeed with clinical-strength OTC first?

The majority of people who seek prescription antiperspirant have not correctly used OTC clinical-strength. The two most common reasons for OTC failure are morning application instead of evening, and skipping the two-night loading period. A formula that cannot form its protective plug because it was washed off in the next morning's shower is not a failed formula; it is a correct formula applied incorrectly.

According to sweathelp.org, the International Hyperhidrosis Society identifies application errors as the most common cause of clinical-strength antiperspirant underperformance. A 4 to 6 week trial with correct evening application on dry skin, including the loading period, is the standard evaluation period before concluding OTC is insufficient. Most people who run this trial correctly see meaningful improvement before reaching the prescription threshold.

DryDry Original on a once-to-twice-weekly evening maintenance schedule, after the initial loading, covers the OTC clinical-strength tier effectively for the majority of users. The full application protocol and common failure modes are in How to Apply Clinical-Strength Antiperspirant and When Pharmacy Antiperspirant Fails: What to Try.

What does the full treatment ladder look like for hyperhidrosis?

The AAD describes a stepwise escalation for hyperhidrosis management that begins with topical treatment and moves to procedural options only when topical options prove insufficient:

  1. Clinical-strength OTC aluminum chloride antiperspirant. First-line treatment. Applied to dry skin in the evening on a weekly maintenance schedule. Effective for the majority of people with primary hyperhidrosis when applied correctly.
  2. Prescription-strength aluminum chloride antiperspirant. Higher concentration, prescribed by a dermatologist. Used when 4 to 6 weeks of correct OTC use does not provide adequate control.
  3. Iontophoresis. A device passes a mild electrical current through water into the skin. Particularly effective for palmar and plantar hyperhidrosis. Requires multiple sessions per week initially, then maintenance. Can be done at home with a prescribed device.
  4. Botulinum toxin injections. Injected into the affected area to temporarily block sweat gland nerve signaling. Effects last 4 to 12 months. Effective for underarms, palms, and feet. Requires repeat treatments.
  5. Oral medications. Anticholinergic medications reduce nerve signaling to sweat glands systemically. Carry systemic side effects. Reserved for severe cases unresponsive to localized treatments.
  6. Surgical options. Endoscopic thoracic sympathectomy and other procedures. Last resort for severe cases. Risk of compensatory sweating in other body areas.

Starting at step one with a correct OTC trial before escalating is the standard approach because clinical-strength OTC is the least invasive and most accessible option. The causes and types of hyperhidrosis that determine which step is appropriate are covered in What Causes Excessive Sweating?

How do you know when to ask a doctor about prescription antiperspirant?

Ask about prescription options when a full 4 to 6 week trial of the highest OTC clinical-strength formula, applied correctly, has not produced a meaningful reduction in sweat volume. Before that threshold, confirm three things: the application is in the evening on dry skin, the two-night loading period was completed in the first week, and the formula used is the highest OTC concentration available rather than a lower-concentration sensitive or light formula.

A dermatologist visit is also appropriate if sweating significantly affects quality of life and the person has never been evaluated medically. Some people with severe primary hyperhidrosis benefit from a dermatologist's guidance on which step to start at, particularly if OTC products have never been tried correctly. The dermatologist may also identify whether secondary hyperhidrosis from an underlying condition is involved, which changes the treatment approach entirely.

More on when to escalate and what triggers a secondary hyperhidrosis evaluation is in Best Antiperspirant for Hyperhidrosis.

Frequently asked questions

Is prescription antiperspirant much stronger than DryDry Original?

Prescription formulas use higher aluminum chloride concentrations than OTC products and may be formulated with different delivery vehicles to maximize penetration. DryDry Original uses the highest concentration available in the DryDry OTC range. For the majority of heavy sweaters, OTC clinical-strength at this level is sufficient. For a smaller group with very high eccrine output, prescription concentration produces deeper and longer-lasting protection. A dermatologist can assess whether the individual's sweat volume requires that escalation.

Can you get prescription antiperspirant without seeing a dermatologist?

In most European countries, prescription-strength antiperspirant requires a physician evaluation and prescription. A general practitioner can often prescribe it, not only a dermatologist, if the clinical case is clear. For someone who has already completed a full OTC trial and can document the results, the path to a prescription consultation is straightforward.

Does using clinical-strength OTC long-term reduce its effectiveness?

No. Aluminum chloride antiperspirant does not become less effective with prolonged use. If protection appears to weaken after extended correct use, the most likely causes are a change in sweat output due to medication, health status, hormonal changes, or seasonal factors, not tolerance to the formula itself. Revisiting application frequency or formula strength typically restores effectiveness.

Are there side effects specific to prescription-strength antiperspirant that OTC does not carry?

Higher aluminum chloride concentrations in prescription formulas carry a proportionally higher risk of localized skin irritation at the application site. The mechanism is the same as OTC irritation, amplified by the higher active ingredient level. Prescription formulas are often prescribed with specific guidance on application frequency and skin preparation to manage this. The systemic safety profile is the same as OTC: no meaningful absorption through intact skin, no systemic side effects from topical use.

Is iontophoresis better than prescription antiperspirant?

Iontophoresis and prescription-strength topical antiperspirant address the same problem through different mechanisms and are at the same step on the AAD treatment ladder. Iontophoresis is particularly effective for palmar and plantar sweating specifically, while prescription-strength topical is effective for underarms. For someone with heavy underarm sweating unresponsive to OTC, prescription-strength topical is typically tried before iontophoresis. For palm or foot sweating unresponsive to OTC, iontophoresis is often the preferred next step per the AAD.

Starting at the right step

The DryDry Original Dab-on (35ml, €18.99) is the clinical-strength OTC starting point for hyperhidrosis management, designed to last up to 7 days per application; results vary by individual. Most heavy sweaters who apply it correctly do not need to escalate to prescription treatment.

Shop DryDry Original →

Christopher Andersson is Founder and CEO of DryDry, a Swedish-made clinical-strength antiperspirant brand for heavy sweating. With 20+ years of experience in the personal care industry, Christopher leads a brand that has sold over 5 million units across European markets since 2006.